Skip to content

Perceptive Advisors portfolio · Q2 2026

Perceptive Advisors LLC · CIK 0001224962 ·13F filings on SEC EDGAR

In Q2 2026, Perceptive Advisors LLC reported 109 positions worth $6.7B. Its largest holding was PRAX at 10.2% of the portfolio, and the top 10 made up 47%. Its largest new position was ASND ($310.4M), and it sold out of 04351P101.

Portfolio value
$6.7B
Positions
109
Top 10 share
47.3%
Changes vs Mar 31, 2026
  • NEW 29
  • ADD 30
  • REDUCE 26
  • EXIT 14

Portfolio map

NEWADDHOLDREDUCE

Each box is a position sized by its value. Color shows the change in shares from the previous quarter. The smallest 69 positions are grouped as one box.

Portfolio history

Q4 2025 to Q2 2026, 3 quarters

Weight of the largest holdings

The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.

PRAXCELCASCENDIS PHARMA A/SSYRERYTMASNDROIVOther

Holding timeline

Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.

< 1%1–3%3–6%6–10%10–20%20–35%≥ 35%

Holdings

Click a holding to see its price chart with the quarters the investor bought or sold.

NameWeightAvg. cost (est.)Latest priceGain/lossValue
MRNAPut
MODERNA INC
1.05%———$70M
XBIPut
SS SPDR S&P BIOTECH ETF
0.71%———$47.5M
EYPTPut
EYEPOINT INC
0.43%———$28.6M
CAPRCall
CAPRICOR THERAPEUTICS INC
0.36%———$24.1M
SLSPut
SELLAS LIFE SCIENCES GROUP I
0.33%———$22.1M
NAMSPut
NEWAMSTERDAM PHARMA CO NV
0.25%———$16.9M
15102KAA8
Celcuity Inc.
PRN
0.22%———$14.6M
CAPRPut
CAPRICOR THERAPEUTICS INC
0.18%———$12M

Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price.

Changes in shares

Change in shares held vs Mar 31, 2026, for the 20 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.

NEWADDREDUCEEXIT

Sold out this quarter

Held on Mar 31, 2026 and not reported for Q2 2026.

StockPrior weightPrior sharesPrior valueChange
04351P101
ASCENDIS PHARMA A/S
6.84%1,531,421$350.3MEXIT
CNTA
CENTESSA PHARMACEUTICALS LTD
4.08%5,258,903$208.9MEXIT
29286M105
ENGENE HOLDINGS INC
0.78%5,827,506$39.7MEXIT
DAWN
DAY ONE BIOPHARMACEUTICALS I
0.74%1,755,799$37.6MEXIT
DRUG
BRIGHT MINDS BIOSCIENCES INC
0.54%377,544$27.5MEXIT
BLTE
BELITE BIO INC - ADR
0.47%151,979$24.2MEXIT
EVMN
EVOMMUNE INC
0.20%448,350$10.3MEXIT
NMRA
NEUMORA THERAPEUTICS INC
0.19%5,104,097$10MEXIT
NBIX
NEUROCRINE BIOSCIENCES INC
0.17%65,050$8.6MEXIT
IRD
OPUS GENETICS INC
0.16%1,835,842$8.4MEXIT
OCULCall
OCULAR THERAPEUTIX INC
0.08%500,000$4.2MEXIT
IKT
INHIBIKASE THERAPEUTICS INC
0.08%2,315,000$3.9MEXIT
APLS
APELLIS PHARMACEUTICALS INC
0.06%80,956$3.3MEXIT
PTN
PALATIN TECHNOLOGIES INC
0.02%61,945$1.1MEXIT

SEC filings for Q2 2026